Dual anti-platelet therapy after DES, how long should it be?

The benefit of aditional antiplatelet therapy (clopidogrel, prasugrel or ticagrelor) of DES is well documented. However, due to the increased bleeding, controvesy remains on the ideal duration of therapy. I have mostly recommended one year dual antiplatelet therapy. 4 trials presented at AHA yesterday have conflicting results. While DAPT suggests 30 months is better than 12, two european studies ISAR-SAFE and ITALIC support that 6 months is not different than longer treatments. What do you usually do? 6, 12 or even more? Individualize? How?
Source: Doc2Doc BMJ Cardiology - Category: Cardiology Authors: Source Type: forums